Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

In search of FDA Approval effect

$2seventy bio (TSVT.US)$ analyst target price 8.2
$OptiNose (OPTN.US)$ all analysts target price 3
$Arcutis Biotherapeutics (ARQT.US)$ avg target price 9.6 (low 4, high 20)
Some of its chart show something good is going to happen, hope no more prank coming from these.
Vanguard and Blackrock also added position on September... ARQT has Vanguard only added position...
still have to wait FDA result though, nothing can be assured. the FDA tracker dot com only provide the schedule, the result is still unknown. hope all of them got approval.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
4
Translate
Report
20K Views
Comment
Sign in to post a comment
Retailers. love biotech small-mid cap stocks w marvelous gain. don't follow. Free ebook:laacademic.com
246Followers
157Following
1619Visitors
Follow